Literature DB >> 21438170

Longitudinal measures of lung function in infants with bronchopulmonary dysplasia.

Amy G Filbrun1, Antonia P Popova, Marisa J Linn, Nancy A McIntosh, Marc B Hershenson.   

Abstract

We previously demonstrated that infants with a history of bronchopulmonary dysplasia (BPD) exhibit airflow obstruction and air trapping. The purpose of this study was to assess longitudinal changes in pulmonary function in infants with a history of BPD over the first 3 years of life, and the relationship to somatic growth. Spirometry was measured using the raised volume rapid thoracoabdominal compression technique, and lung volumes measured by plethysmography. Eighteen infants (mean gestational age ± SD 27.3 ± 2.2 weeks, birthweight 971 ± 259 g) underwent two lung function studies. Average age at first test was 58.8 weeks. Spirometry demonstrated significant reductions in forced expiratory volume in 0.5 sec (FEV(0.5), 76.0 ± 15.9% predicted, Z-score -2.13 ± 1.69), forced expiratory flow at 75% of expired forced vital capacity (FEF(75), 54.8 ± 31.1%, -3.58 ± 2.73), and FEF(25-75) (67.8 ± 33.3%, -1.79 ± 1.76). Group mean total lung capacity (TLC) was in the low normal range (82.9 ± 13.5% predicted) and residual volume (RV)/TLC was mildly elevated (122.4 ± 38.2% predicted). Repeat testing was performed an average of 32.7 weeks after initial testing. At re-evaluation, group mean lung volumes and flows tracked at or near their previous values; thus, in general, there was a lack of catch-up growth. However, compared to infants with below average or average somatic growth (as represented by g/day), infants with above average growth showed significantly greater improvements in percent predicted FVC, FEV(0.5), TLC, and RV/TLC (all P < 0.05, ANOVA). We conclude that longitudinal measures of pulmonary function in infants and young children with BPD demonstrate significant airflow obstruction and modest restriction, which tends to persist with time. On the other hand, infants with above average somatic growth showed greater lung growth than their peers. Additional studies examining the effects of various nutritional regimens on lung function are warranted.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21438170      PMCID: PMC3801101          DOI: 10.1002/ppul.21378

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  33 in total

1.  Assessment of pulmonary function in resolving chronic lung disease of prematurity.

Authors:  R Iles; A T Edmunds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

2.  Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992.

Authors:  Lex W Doyle
Journal:  Pediatr Pulmonol       Date:  2006-06

Review 3.  The role of nutrition in the prevention and management of bronchopulmonary dysplasia.

Authors:  Manoj A Biniwale; Richard A Ehrenkranz
Journal:  Semin Perinatol       Date:  2006-08       Impact factor: 3.300

4.  Reduced lung function in healthy preterm infants in the first months of life.

Authors:  Luciana Friedrich; Renato T Stein; Paulo M C Pitrez; Andrea L Corso; Marcus H Jones
Journal:  Am J Respir Crit Care Med       Date:  2005-12-01       Impact factor: 21.405

5.  Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia.

Authors:  Anette M Kunig; Vivek Balasubramaniam; Neil E Markham; Gregory Seedorf; Jason Gien; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-07-07       Impact factor: 5.464

6.  Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood.

Authors:  Lucile Bott; Laurent Béghin; Patrick Devos; Véronique Pierrat; Régis Matran; Frédéric Gottrand
Journal:  Pediatr Res       Date:  2006-07-20       Impact factor: 3.756

7.  Interleukin (IL)-1 beta in tracheal aspirates from premature infants induces airway epithelial cell IL-8 expression via an NF-kappa B dependent pathway.

Authors:  Thomas K Shimotake; Farzana M Izhar; Kandelaria Rumilla; Jing Li; Alan Tan; Kristen Page; Allan R Brasier; Michael D Schreiber; Marc B Hershenson
Journal:  Pediatr Res       Date:  2004-10-20       Impact factor: 3.756

8.  Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study.

Authors:  P Toti; G Buonocore; P Tanganelli; A M Catella; M L Palmeri; R Vatti; T A Seemayer
Journal:  Pediatr Pulmonol       Date:  1997-07

9.  Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.

Authors:  Bernard Thébaud; Faruqa Ladha; Evangelos D Michelakis; Monika Sawicka; Gavin Thurston; Farah Eaton; Kyoko Hashimoto; Gwyneth Harry; Alois Haromy; Greg Korbutt; Stephen L Archer
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

10.  Bronchial responsiveness to methacholine and adenosine 5'-monophosphate in preschool children with bronchopulmonary dysplasia.

Authors:  Do Kyun Kim; Sun Hee Choi; Jinho Yu; Young Yoo; Beyong ll Kim; Young Yull Koh
Journal:  Pediatr Pulmonol       Date:  2006-06
View more
  19 in total

1.  Retrospective Analysis of an Interdisciplinary Ventilator Care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia.

Authors:  Jason Gien; John Kinsella; Jodi Thrasher; Alicia Grenolds; Steven H Abman; Christopher D Baker
Journal:  Am J Perinatol       Date:  2016-06-29       Impact factor: 1.862

Review 2.  Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.

Authors:  Jessica Y Islam; Roberta L Keller; Judy L Aschner; Tina V Hartert; Paul E Moore
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

Review 3.  Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.

Authors:  Renjithkumar Kalikkot Thekkeveedu; Milenka Cuevas Guaman; Binoy Shivanna
Journal:  Respir Med       Date:  2017-10-24       Impact factor: 3.415

Review 4.  Pulmonary function testing in young children.

Authors:  Hugo Escobar; Terrence W Carver
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

5.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

Review 6.  The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.

Authors:  Cindy T McEvoy; Judy L Aschner
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

7.  Persistently elevated right ventricular index of myocardial performance in preterm infants with incipient bronchopulmonary dysplasia.

Authors:  Christoph Czernik; Stefanie Rhode; Boris Metze; Gerd Schmalisch; Christoph Bührer
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

8.  Development of lung function in very low birth weight infants with or without bronchopulmonary dysplasia: longitudinal assessment during the first 15 months of corrected age.

Authors:  Gerd Schmalisch; Silke Wilitzki; Charles Christoph Roehr; Hans Proquitté; Christoph Bührer
Journal:  BMC Pediatr       Date:  2012-03-23       Impact factor: 2.125

Review 9.  Updates on Functional Characterization of Bronchopulmonary Dysplasia - The Contribution of Lung Function Testing.

Authors:  Anne Greenough; Anoop Pahuja
Journal:  Front Med (Lausanne)       Date:  2015-05-29

10.  Family history of asthma influences outpatient respiratory outcomes in children with BPD.

Authors:  Julianne R McGlynn; Brianna C Aoyama; Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2021-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.